Journal of Surgical Research
Volume 140, Issue 1 , Pages 31-35 , 1 June 2007

The Use of Adjusted Preoperative CA 19-9 to Predict the Recurrence of Resectable Pancreatic Cancer

Received 10 July 2006

References 

  1. Pingpank JF, Hoffman JP, Ross EA, et al. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastroint Surg. 2001;5:121
  2. Breslin TM, Hess KR, Harbison DB, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. Ann Surg Oncol. 2001;8:123
  3. Nishida K, Kaneko T, Yondeda M, et al. Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis. J Surg Oncol. 1999;71:140
  4. Lamerz R. Role of tumor markers, cytogenetics. Ann Oncol. 1999;10:145
  5. Glenn J, Steinberg WM, Kurtzman SH, et al. Evaluation of the utility of a radioimmunoassay for serum CA 19-9 levels in patients before and after treatment of carcinoma of the pancreas. J Clin Oncol. 1988;6:462
  6. Sperti C, Pasquali C, Catalini S, et al. CA 19-9 as a prognostic index after resection for pancreatic cancer. J Surg Oncol. 1993;52:137
  7. Montgomery RC, Hoffman JP, Riley LB, et al. Prediction of recurrence and survival by postresection CA 19-9 values in patients with adenocarcinoma of the pancreas. Ann Surg Oncol. 1997;4:551
  8. Van den Hael SJ, de Vries XH, Speelaman P, et al. Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract. Antimicrob Agents Chemother. 1996;40:2658
  9. Leung JW, Chan CY, Lai CW, et al. Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatin. Antimicrob Agents Chemother. 1992;36:2057
  10. Schlieman MG, Ho HS, Bold RJ. Utility of tumor marker in determining respectability of pancreatic cancer. Arch Surg. 2003;138:951
  11. Gudjonsson B. Cancer of the pancreas (Fifty years of surgery). Cancer. 1987;60:2284
  12. Tredel M, Schwall G, Saeger HD. Survival after pancreaticoduodenectomy (One hundred eighteen consecutive resections without an operative mortality). Ann Surg. 1990;211:447
  13. Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 1991;161:120
  14. Lillemoe KD, Yeo CJ, Cameron JL. Pancreatic cancer: State-of-the-art care. CA Cancer Clin. 2000;50:241
  15. Magnani JL, Steplewski Z, Koprowski H, et al. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res. 1983;43:5489
  16. Tempero MA, Uchida E, Takasaki H, et al. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. Cancer Res. 1987;47:5501
  17. Koprowski H, Steplewski Z, Mitchell K, et al. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genetics. 1979;5:957
  18. Halm U, Schumaa T, Schiefke I, et al. Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer. 2000;82:1013
  19. Willett CG, Daly WJ, Warshaw AL. CA 19-9 is an index of response to neoadjuvant chemoradiation therapy in pancreatic cancer. Am J Surg. 1996;17:350
  20. Karachristos A, Scarmeas N, Hoffman JP. CA 19-9 levels predicts results of staging laparoscopy in pancreatic cancer. J Gastroint Surg. 2005;9:1286
  21. Beretta E, Malesci A, Zerbi A, et al. Serum CA 19-9 in the post surgical follow-up of patients with pancreatic cancer. Cancer. 1987;60:2428
  22. Berger AC, Meszoely IM, Ross EA, et al. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with respectable pancreatic adenocarcinoma. Ann Surg Oncol. 2004;11:644
  23. Ni XG, Bai XF, Mao YL, et al. The clinical value of serum CEA, CA 19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Eur J Surg Onco. 2005;31:164

PII: S0022-4804(06)00530-0

doi: 10.1016/j.jss.2006.10.007

Journal of Surgical Research
Volume 140, Issue 1 , Pages 31-35 , 1 June 2007